Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased Expression of UBE2T Predicting Poor Survival of Epithelial Ovarian Cancer: Based on Comprehensive Analysis of UBE2s, Clinical Samples, and the GEO Database.

DNA and cell biology - 1 Jan 2021

Zou Ruoyao, Xu Haoya, Li Feifei, Wang Shengke, Zhu Liancheng

Abstract excerpt

Ubiquitin-conjugating enzymes E2 (UBE2) have been reported in the microenvironment of various malignant tumors, but their correlation with ovarian cancer (OC) remains elusive. This study aimed to systematically analyze the expression patterns, prognostic value, genetic variation, and biological functions of 12 members of the UBE2 gene family in OC through the Oncomine, Gene Expression Profiling Interactive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Connectin

Share to Gene Expression Regulation, Neoplastic

Share to Ovarian Neoplasms

Share to Tumor Suppressor Protein p53

Share to Ubiquitin-Conjugating Enzymes

Share to Up-Regulation

Source

Identifiers

PMID: 33180631
DOI: 10.1089/dna.2020.5823

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased Expression of UBE2T Predicting Poor Survival of Epithelial Ovarian Cancer: Based on Comprehensive Analysis of UBE2s, Clinical Samples, and the GEO Database.PMID 33180631Read ↗

Increased expression of UBE2T predicting poor survival of ovarian cancer: based on comprehensive analysis of UBE2s, clinical samples and the GEO databaseSemantic proximity Read ↗

Increased expression of UBE2T predicting poor survival of ovarian cancer: based on bioinformatics analysis of UBE2s, clinical samples and the GEO databaseSemantic proximity Read ↗

High UBE2T mRNA expression and its prognostic significance in Ovarian cancer: a study based on data miningSemantic proximity Read ↗

High UBE2T mRNA expression and its prognostic significance in Ovarian cancer: a study based on data miningSemantic proximity Read ↗

UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancerSemantic proximity Read ↗

UBE2T is a diagnostic and prognostic biomarker for endometrial cancerSemantic proximity Read ↗

Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1Semantic proximity Read ↗

Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancerSemantic proximity Read ↗

UBE2A as a prognostic indicator across human cancers: Insights from multi‑omics and immune landscape analysesSemantic proximity Read ↗

A Comprehensive Bioinformatics Analysis of UBE2C in CancersSemantic proximity Read ↗

Bioinformatics-based pan-cancer analysis of UBE2CSemantic proximity Read ↗

Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.